iNtRON Biotechnology Inc Working Capital to Net Assets Ratio
iNtRON Biotechnology Inc working capital to net assets ratio. iNtRON Biotechnology Inc (048530) has a Working Capital to Net Assets ratio of 57.7% as of September 2025. Working capital of ₩42.70 Billion (current assets of ₩47.10 Billion minus current liabilities of ₩4.40 Billion) is measured against net assets of ₩73.98 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 048530 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of iNtRON Biotechnology Inc (2012–2024)
Working capital to net assets ratio of iNtRON Biotechnology Inc from 2012 to 2024. This chart shows how iNtRON Biotechnology Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 57.7%, reflecting working capital of ₩42.70 Billion against net assets of ₩73.98 Billion KRW. See 048530 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
iNtRON Biotechnology Inc Working Capital to Net Assets Ratio by Year (2012–2024)
iNtRON Biotechnology Inc working capital to net assets ratio by year from 2012 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for iNtRON Biotechnology Inc from 2012 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 048530 current and non-current assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 60.7% | ₩50.89 Billion | ₩83.77 Billion | ₩52.23 Billion | ₩1.34 Billion | ▼ -1.5 pp |
| 2023 | 62.2% | ₩60.19 Billion | ₩96.73 Billion | ₩60.98 Billion | ₩785.97 Million | ▼ -14.7 pp |
| 2022 | 77.0% | ₩81.71 Billion | ₩106.18 Billion | ₩113.93 Billion | ₩32.22 Billion | ▼ -14.1 pp |
| 2021 | 91.0% | ₩92.26 Billion | ₩101.35 Billion | ₩125.51 Billion | ₩33.25 Billion | ▲ +10.7 pp |
| 2020 | 80.4% | ₩68.62 Billion | ₩85.38 Billion | ₩81.33 Billion | ₩12.70 Billion | ▼ -28.3 pp |
| 2019 | 108.7% | ₩70.61 Billion | ₩64.96 Billion | ₩75.29 Billion | ₩4.68 Billion | ▲ +42.2 pp |
| 2018 | 66.5% | ₩25.99 Billion | ₩39.09 Billion | ₩40.16 Billion | ₩14.17 Billion | ▲ +9.3 pp |
| 2017 | 57.1% | ₩17.28 Billion | ₩30.24 Billion | ₩31.10 Billion | ₩13.82 Billion | ▲ +2.9 pp |
| 2016 | 54.2% | ₩26.65 Billion | ₩49.15 Billion | ₩34.76 Billion | ₩8.11 Billion | ▲ +7.8 pp |
| 2015 | 46.4% | ₩15.99 Billion | ₩34.44 Billion | ₩19.26 Billion | ₩3.27 Billion | ▲ +12.2 pp |
| 2012 | 34.2% | ₩4.08 Billion | ₩11.93 Billion | ₩8.26 Billion | ₩4.18 Billion | — |